123 related articles for article (PubMed ID: 4009489)
1. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
Groen K; Breimer DD; van Bezooijen CF
Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
[TBL] [Abstract][Full Text] [Related]
3. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
Adedoyin A; Aarons L; Houston JB
Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
[TBL] [Abstract][Full Text] [Related]
5. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.
Schellens JH; van der Wart JH; Danhof M; van der Velde EA; Breimer DD
Br J Clin Pharmacol; 1988 Oct; 26(4):373-84. PubMed ID: 3190987
[TBL] [Abstract][Full Text] [Related]
8. Comparison of theophylline and theobromine metabolism in man.
Birkett DJ; Dahlqvist R; Miners JO; Lelo A; Billing B
Drug Metab Dispos; 1985; 13(6):725-8. PubMed ID: 2867879
[TBL] [Abstract][Full Text] [Related]
9. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
10. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of theophylline metabolism in man.
Miller CA; Slusher LB; Vesell ES
J Clin Invest; 1985 May; 75(5):1415-25. PubMed ID: 4039734
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
13. Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.
Schellens JH; van der Wart JH; Brugman M; Breimer DD
J Pharmacol Exp Ther; 1989 May; 249(2):638-45. PubMed ID: 2724144
[TBL] [Abstract][Full Text] [Related]
14. Quinidine does not alter antipyrine metabolism.
Bowles SK; Cardozo L; Edwards DJ
J Clin Pharmacol; 1990 Mar; 30(3):267-71. PubMed ID: 2312782
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
van Bezooijen CF; van Oorschot RM
J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
[TBL] [Abstract][Full Text] [Related]
16. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach.
Schellens JH; Janssens AR; van der Wart JH; van der Velde EA; Breimer DD
Eur J Clin Invest; 1989 Oct; 19(5):472-9. PubMed ID: 2511024
[TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
[TBL] [Abstract][Full Text] [Related]
19. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
[TBL] [Abstract][Full Text] [Related]
20. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
Bachmann KA; Yang C; Jahn D; Schwartz J
Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
